[Synthetic protease inhibitors for human acute pancreatitis]
- PMID: 9852723
[Synthetic protease inhibitors for human acute pancreatitis]
Similar articles
-
Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography.Gastrointest Endosc. 1997 May;45(5):447-8. Gastrointest Endosc. 1997. PMID: 9165340 No abstract available.
-
Protease inhibitors for prevention of ERCP pancreatitis: can we afford the price of success?Am J Gastroenterol. 1997 Jun;92(6):1067-8. Am J Gastroenterol. 1997. PMID: 9177543 No abstract available.
-
Prevention of ERCP-induced pancreatitis: success at last.Gastroenterology. 1997 Apr;112(4):1415-7. doi: 10.1016/s0016-5085(97)70160-4. Gastroenterology. 1997. PMID: 9098032 No abstract available.
-
[Can post-ERCP acute pancreatitis be predicted and prevented?].Gastroenterol Clin Biol. 2001 Jan;25(1 Suppl):1S241-6. Gastroenterol Clin Biol. 2001. PMID: 11223596 Review. French. No abstract available.
-
Treatment of acute pancreatitis with protease inhibitors: a meta-analysis.Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1287-93. doi: 10.1097/00042737-200412000-00009. Eur J Gastroenterol Hepatol. 2004. PMID: 15618834 Review.
Cited by
-
Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.J Gastroenterol. 2007 Feb;42(2):161-7. doi: 10.1007/s00535-006-1986-8. Epub 2007 Mar 12. J Gastroenterol. 2007. PMID: 17351806 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical